600222 太龙药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.0973.2052.766-4.4700.385
总资产报酬率 ROA (%)0.0431.4301.213-1.9540.167
投入资产回报率 ROIC (%)0.0561.9701.775-2.5040.189

边际利润分析
销售毛利率 (%)26.81125.59327.28224.07728.860
营业利润率 (%)0.8151.8402.134-3.6102.219
息税前利润/营业总收入 (%)5.3364.7734.662-0.9845.701
净利润/营业总收入 (%)0.8142.7552.166-3.8640.422

收益指标分析
经营活动净收益/利润总额(%)23.97156.06879.25640.946909.530
价值变动净收益/利润总额(%)3.87030.433-14.95213.385-87.463
营业外收支净额/利润总额(%)0.382-1.839-2.80314.568-377.957

偿债能力分析
流动比率 (X)1.1281.0621.2081.1771.178
速动比率 (X)0.9220.8570.9320.9160.947
资产负债率 (%)54.25653.40054.61455.24853.019
带息债务/全部投入资本 (%)41.76239.08130.32733.42139.474
股东权益/带息债务 (%)134.286149.609213.566190.278127.520
股东权益/负债合计 (%)81.59284.50380.80578.81482.772
利息保障倍数 (X)1.1811.6091.803-0.3041.089

营运能力分析
应收账款周转天数 (天)251.252153.986126.000112.925113.166
存货周转天数 (天)139.316102.572108.344100.644115.115